Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 200 of 563 entries
View as:

Vaccine Therapy With or Without Donor Lymphocyte Infusion in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Multiple Myeloma Undergoing Donor Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT00469820 Org: User:
Start: 04/30/07 End: 03/31/10 Due: 03/31/11

Cyclophosphamide Plus T-Cell Transplantation for Patients With Hematologic Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT00356928 Org: User:
Start: 10/31/06 End: 05/31/11 Due: 05/31/12

Neoadjuvant Dupilumab in Men With Localized High-Risk Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03886493 Org: User:
Start: 08/28/19 End: 10/06/20 Due: 10/06/21

Liposomal Doxorubicin (Lipo-Dox) in Patients With Brain Metastasis From Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00465673 Org: User:
Start: 09/30/05 End: 07/31/09 Due: 07/31/10

An Early Safety and Efficacy Study of Ascites Management: Standard Paracentesis or Early Intervention With Pleurx Catheters in Patients With Malignant Ascites

Phase: N/A Priority: Normal
NCT ID: NCT01077063 Org: User:
Start: 02/28/10 End: 08/31/13 Due: 08/31/14

Freehand Ultrasound Elasticity Imaging in Liver Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00942383 Org: User:
Start: 09/30/07 End: 06/13/12 Due: 06/13/13

Docetaxel With or Without Ascorbic Acid in Treating Patients With Metastatic Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02516670 Org: User:
Start: 06/20/16 End: 10/14/21 Due: 10/14/22

Stereotactic Body Radiation With Nelfinavir for Oligometastases

Phase: N/A Priority: Normal
NCT ID: NCT01728779 Org: User:
Start: 01/08/14 End: 12/31/20 Due: 12/31/21

Neoantigen-Targeted Vaccine Combined With Anti-PD-1 Antibody for Patients With Stage IV MMR-p Colon and Pancreatic Ductal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04799431 Org: User:
Start: 05/03/23 End: 05/03/23 Due: 05/03/24

Celecoxib Compared With No Treatment Before Surgery in Treating Patients With Localized Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00022399 Org: User:
Start: 04/25/02 End: 01/31/05 Due: 01/31/06

Intravesical Gemcitabine and Docetaxel for BCG naïve Non-muscle Invasive Bladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04386746 Org: User:
Start: 07/29/20 End: 11/30/25 Due: 11/30/26

Iodine I 131 Tositumomab or Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00416312 Org: User:
Start: 07/31/06 End: 10/31/09 Due: 10/31/10

Infrastructure for Developing Gastrointestinal Cancer Prognostic and Predictive Markers

Phase: N/A Priority: Normal
NCT ID: NCT00539318 Org: User:
Start: 08/31/07 End: 07/31/09 Due: 07/31/10

Maintenance Rituximab With mTor Inhibition After High-dose Consolidative Therapy in Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01665768 Org: User:
Start: 09/30/12 End: 08/31/20 Due: 08/31/21

Anti-LAG-3 Alone & in Combination w/ Nivolumab Treating Patients w/ Recurrent GBM (Anti-CD137 Arm Closed 10/16/18)

Phase: N/A Priority: Normal
NCT ID: NCT02658981 Org: User:
Start: 08/24/16 End: 10/03/23 Due: 10/03/24

Vaccine Therapy With or Without Imiquimod in Treating Patients With Grade 3 Cervical Intraepithelial Neoplasia

Phase: N/A Priority: Normal
NCT ID: NCT00788164 Org: User:
Start: 11/30/08 End: 08/31/23 Due: 08/31/24

Resiliency in Older Adults Undergoing Bone Marrow Transplant

Phase: N/A Priority: Normal
NCT ID: NCT04188678 Org: User:
Start: 09/28/18 End: 09/30/25 Due: 09/30/26

Neoadjuvant Immune Checkpoint Blockade in Resectable Malignant Pleural Mesothelioma

Phase: N/A Priority: Normal
NCT ID: NCT03918252 Org: User:
Start: 10/02/19 End: 06/30/27 Due: 06/30/28

A Randomized Phase II Study of SUBATM-itraconazole in Patients With Untreated Squamous NSCLC.

Phase: N/A Priority: Normal
NCT ID: NCT01752023 Org: User:
Start: 03/31/13 End: 04/30/14 Due: 04/30/15

Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00003414 Org: User:
Start: 10/31/97 End: 05/31/04 Due: 05/31/05

Evaluation of Prostate-specific Membrane Antigen (PSMA)-Based PET Imaging of Primary Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01496157 Org: User:
Start: 09/11/12 End: 09/17/17 Due: 09/17/18

FOLFIRINOX Followed by Ipilimumab With Pancreatic Tumor Vaccine in Treatment of Metastatic Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01896869 Org: User:
Start: 11/30/13 End: 05/03/19 Due: 05/03/20

Robot-Assisted MRI-Guided Prostate Biopsy

Phase: N/A Priority: Normal
NCT ID: NCT02080052 Org: User:
Start: 07/25/13 End: 01/31/16 Due: 01/31/17

Zoledronic Acid in Aromatase Inhibitor Induced Musculoskeletal Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT01194440 Org: User:
Start: 02/28/11 End: 01/31/14 Due: 01/31/15

Safety and Efficacy Study of I-131 Tositumomab in Patients With Relapsed/Refractory Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00484874 Org: User:
Start: 06/30/07 End: 11/30/15 Due: 11/30/16